2-Chloroquinoxaline → HCID 18689870, compound
Reaction equation
Cl[C:2]1[CH:11]=[N:10][C:9]2[C:4](=[CH:5][CH:6]=[CH:7][CH:8]=2)[N:3]=1.FC(F)(F)S(O[C:18]1[CH2:24][CH:23]2[N:25]([CH3:26])[CH:20]([CH2:21][CH2:22]2)[CH:19]=1)(=O)=O.C[Sn](C)C.C[Sn](C)C.[Cl-].[Li+].[F-].[K+]>O1CCOCC1.C(OCC)(=O)C>[N:3]1[C:4]2[C:9](=[CH:8][CH:7]=[CH:6][CH:5]=2)[N:10]=[CH:11][C:2]=1[C:18]1[CH2:19][CH:20]2[N:25]([CH3:26])[CH:23]([CH2:22][CH2:21]2)[CH:24]=1Participants
8
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
A mixture of 2-chloroquinoxaline, 3-trifluoromethanesulfonyloxy-8-methyl-8-azabicyclo[3.2.1]-oct-2-ene, hexamethylditin, lithium chloride, and [tetrakis(triphenylphosphine)]palladium in dioxane is stirred at reflux for 18 hours. The reaction mixture is cooled to room temperature and then poured into a mixture of saturated aqueous potassium fluoride and ethyl acetate. After stirring for two hours, the phases are separated. The organic phase is washed with saturated aqueous sodium chloride, dried over magnesium sulfate and concentrated under reduced pressure. The residue is subjected to flash silica gel chromatography. Fractions containing product are combined and concentrated under reduced pressure to provide the title compound.
Workup
- temperatureat reflux for 18 hours
- stirringAfter stirring for two hours
- customthe phases are separated
- washThe organic phase is washed with saturated aqueous sodium chloride
- dry with materialdried over magnesium sulfate
- concentrationconcentrated under reduced pressure
- additionFractions containing product
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-5b592d0cdb814aa581c5c245ff306898
- Source dataset
- uspto-grants-2000_08
- Patent number
- US06107307
Reaction notes
Loading…